Governing Board

The Governing Board is the main decision-making body of the Innovative Medicines Initiative (IMI). It carries the overall responsibility for the operations of the undertaking and oversees the implementation of its activities. It therefore guarantees the fulfilment of the objectives set by the organisation.

The Governing Board is composed of 10 Board members representing equally our two Founding Members: 5 from the European Commission, representing the European Community, and 5 from the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the research-based pharmaceutical industry in Europe. In addition, our Associated Partners may take part in Governing Board discussions that concern their association, although they do not have voting rights.

The way the Governing Board works is set out in the Governing Board Rules of Procedure. Lists of the decisions taken by the Governing Board under the IMI2 programme are published on this page.

The roles of chair and deputy chair are held alternately by representatives of the European Commission and representatives of EFPIA.  

 

Members of the IMI Governing Board

 

Representatives of EFPIA

 

Olivier Laureau

Olivier Laureau

Chair of the IMI Governing Board
President of Servier group

CV

Declaration of interests

 

nathalie_moll220.jpg

Nathalie Moll

Director General of EFPIA

CV

Declaration of interests

 

 

salah_dine_chibout220.jpg

Salah-Dine Chibout

Global Head of Discovery and Investigational Safety at Novartis, Chairman of the EFPIA Research and Innovation Strategy Working Group

CV

Declaration of interests

 

carlo_incerti220.jpg

Jacky Vonderscher

CEO of Enyo Pharma S.A., member of the European Biopharmaceutical Enterprises Board

CV

Declaration of interests

 

 

paulus_stoffels220.jpg

Paul Stoffels

Chief Scientific Officer at Johnson & Johnson, Worldwide Chairman of Janssen Pharmaceutical Companies of Johnson & Johnson

CV

Declaration of interests

 

Representatives of the European Commission

 

 

Irene%20bio.jpg

 

Irene NORSTEDT

Deputy Chair of the IMI Governing Board

Director (acting) - People within the Directorate-General for Research and Innovation, European Commission

CV

Declaration of interests

 

carlo_pettinelli220.jpg

Carlo Pettinelli

Director - Consumer, Environmental and Health Technologies within the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission

CV

Declaration of interests

 

 

andrzej_rys220.jpg

Andrzej Jan Rys

Director - Health systems, medical products and innovation within the Directorate-General for Health and Food Safety, European Commission

CV

Declaration of interests

 

photo.jpg

Barbara Kerstiëns

Head of Unit - ‘Combatting Diseases’ in the People Directorate of the Directorate-General for Research and Innovation, European Commission

CV

Declaration of interests

 

photo.jpg

Maria Pilar Aguar Fernandez

Head of Unit - Health Innovations within the Directorate-General for Research and Innovation, European Commission

CV

Declaration of interests

Alternate Members of the IMI Governing Board

Magda Chlebus Executive Director, Science Policy and Regulatory Affairs, EFPIA   Declaration of interests

James Eshelby Executive Director, Head of Pfizer IMI Office External R&D Innovation   Declaration of interests

Stefano Soro European Commission, Head of Unit, DG GROW, Food Industry   Declaration of interests

Sylvain Giraud European Commission, Head of Unit, DG SANTE, Medical products: quality, safety, innovation  Declaration of interests

Governing Board decisions

  • List of decisions   taken by the IMI2 Governing Board from 1 January to 30 June 2020
  • List of decisions   taken by the IMI2 Governing Board from 1 January to 31 December 2019
  • List of decisions   taken by the IMI2 Governing Board from 1 January to 31 December 2018
  • List of decisions   taken by the IMI2 Governing Board from 1 January to 31 December 2017
  • List of decisions   taken by the IMI2 Governing Board from 1 July to 31 December 2016
  • List of decisions   taken by the IMI2 Governing Board from 1 January to 30 June 2016
  • List of decisions   taken by the IMI2 Governing Board from 24 September to 31 December 2015
  • List of decisions   taken by the IMI2 Governing Board from 1 July to 23 September 2015
  • List of decisions   taken by the IMI2 Governing Board from 1 January to 30 June 2015
  • List of decisions   taken by the IMI2 Governing Board in 2014 (from the establishment of IMI2 JU on 27 June 2014 to the end of 2014)